Effects of aging on the effectiveness of smoking cessation medication Public Deposited

http://ir.library.oregonstate.edu/concern/articles/37720f564

This is the publisher’s final pdf. The published article is copyrighted by the author(s) and published by Impact Journals. The published article can be found at:  http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget

Descriptions

Attribute NameValues
Creator
Abstract or Summary
  • Background: Considering the pharmacokinetic and pharmacodynamic aspects of different medications, it is plausible that the age of a smoker could affect the half-life of these drugs. The aim of this study was to compare the effectiveness of smoking cessation drugs (nicotine replacement therapy, bupropion, and varenicline) used either in isolation or in combination in adults under and over 60 years of age. Methods: Data were collected from 940 Brazilian patients participating in a smoking cessation program. Participants were prescribed smoking cessation medication to be used for at least 12 weeks and were followed for 52 weeks. Results: Cessation rates were significantly different among younger and older participants who were using nicotine replacement therapy (NRT) alone. Being over 60 years of age was significantly associated with increased cessation success among those who used NRT alone (OR 2.34, 95% CI: 1.36 to 4.04, p = 0.002). The effectiveness of varenicline and bupropion were not significantly different according to age groups. Conclusion: Using age as a predictor for tailoring smoking cessation drugs might potentially lead to a more individualized prescription of smoking cessation therapy. These results should be tested in randomized controlled trials.
Resource Type
DOI
Date Available
Date Issued
Citation
  • Scholz, J., Junior Lima Santos, P. C., Buzo, C. G., Moreira, L. N., Abe, T. M., Gaya, P. V., ... & Pereira, A. C. (2016). Effects of aging on the effectiveness of smoking cessation medication. Oncotarget, 7(21), 30032-30036. doi:10.18632/oncotarget.9090
Series
Keyword
Rights Statement
Funding Statement (additional comments about funding)
Publisher
Peer Reviewed
Language
Replaces
Additional Information
  • description.provenance : Made available in DSpace on 2016-07-20T19:23:25Z (GMT). No. of bitstreams: 2 krauserp388746676.zip: 332509 bytes, checksum: 7c98a6d60346ffb6865edfec033b06b6 (MD5) ScholzEffectsofAgingontheEffectiveness.pdf: 659127 bytes, checksum: f30eac1f83a6583a2f35769d231c1ecd (MD5) Previous issue date: 2016-05-24
  • description.provenance : Submitted by Open Access (openaccess@library.oregonstate.edu) on 2016-07-20T16:00:30Z No. of bitstreams: 1 ScholzEffectsofAgingontheEffectiveness.pdf: 659127 bytes, checksum: f30eac1f83a6583a2f35769d231c1ecd (MD5)
  • description.provenance : Approved for entry into archive by Patricia Black(patricia.black@oregonstate.edu) on 2016-07-20T19:23:25Z (GMT) No. of bitstreams: 2 krauserp388746676.zip: 332509 bytes, checksum: 7c98a6d60346ffb6865edfec033b06b6 (MD5) ScholzEffectsofAgingontheEffectiveness.pdf: 659127 bytes, checksum: f30eac1f83a6583a2f35769d231c1ecd (MD5)

Relationships

Parents:

This work has no parents.

Last modified

Downloadable Content

Download PDF

Items